Bioextrax Investor Relations Material
Latest events
Q1 2025
Bioextrax
Q1 2025
20 May, 2025
Q4 2024
25 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bioextrax
Access all reports
Bioextrax AB develops and commercializes a bio-extraction platform technology delivering high purity active ingredients from non-traditional sources with lower cost than traditional extraction methods like CO2. Bioextrax has developed specific patented and protected technology platforms to produce active pharmaceutical ingredients (APIs) such as Omega 3, polyunsaturated fatty acids, astaxanthin and squalene. Bioextrax AB is haedquartered in Lund, Sweden.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BIOEX
Country
🇸🇪 Sweden